molab.ai is a biotechnology startup founded in 2022 with the slogan "Leading AI technology to create better molecules faster." The company is focused on building a robust platform for next-generation small molecule drugs that leverage optimal modes of action and in-silico multi-parameter optimization. Their recent achievement includes securing a Seed Round investment on 16 May 2022 with participation from Picus Capital and FTTF. The startup invites individuals interested in collaborating with or contributing to a purpose-driven AI company that combines scientific excellence, impact orientation, and entrepreneurial drive to join them on their journey.
